Skip to content
Search

Latest Stories

Hypovase 500mg tablets face supply disruption

Shilpa Sharma
By Shilpa SharmaNov 29, 2021
Shilpa Sharma
See Full Bio

Hypovase (prazosin) 500 microgram tablets, manufactured by drug major Pfizer, will remain out of stock until mid-January 2022 due to a manufacturing issue.

The Department of Health and Social Care (DHSC) and NHS England and Improvement (NHSE&I) have issued a supply disruption alert for the medicine that is used to treat heart-related troubles.

Pfizer, the sole supplier of prazosin 500mg tablets in the UK, is out of stock from late November 2021, and had discontinued the Hypovase® (prazosin) 1mg tablets in May 2021.

Advice for healthcare professionals 

In the given situation, prescribers need to review all affected patients to discuss management plans.

Meanwhile, alternative medicine alpha blockers remain available to support an uplift in demand.

Unlicensed supplies of prazosin 500 microgram tablets have also been sourced and may be considered where the alternative medicine is inappropriate.

In case a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘prazosin 500 microgram tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

uknhse&ipfizerpharmacistssupply disruptionthe department of health and social care (dhsc)hypovase 500mgpharmacy

Related News

GPs to play crucial role in transforming Wales’ health service
News

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

NPA and IPA urge NHS England to release pharmacy economic analysis immediately
News

Pharmacy bodies demand immediate release of economic analysis

Benefits of embracing OTC medicines
Opinion

Self-care revolution: Benefits of embracing OTC medicines

The advantages of a collaborative working model
Guest Blog

The potential of collaborative working to transform businesses

More For You

NHS England to halve workforce to cut costs

“We are entering a period of critical transformation for our NHS," says Wes Streeting.

Getty Images

NHS England to halve workforce in biggest reshaping in over a decade

NHS England and the Department of Health and Social Care (DHSC) are set for significant downsizing as they strengthen collaboration under the 10-Year Health Plan to build a future-fit health service.

As part of this transformation, the NHSE workforce is expected to be reduced by up to 50% to cut costs and eliminate duplication with DHSC officials.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less
Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc